Astra Signs Global License Agreement for Advanced Chemistry Development's Spectroscopic Data Management and Property Prediction Software

Media Contact

Tara Sinclair
Media Coordinator
media@acdlabs.com
(416) 368-3435 ext. 297
(416) 368-5596

Latest News

Even More Choice with Updated, Free HPLC Column Selection Software - May 2008

	e-mail alerts
	RSS feed

TORONTO - November 1, 1998 - Advanced Chemistry Development Inc and Astra AB have reached a three-year agreement that provides Astra with global use of Advanced Chemistry's property prediction and experimental data management software. Under the agreement, Astra chemists at 13 research facilities worldwide will have unlimited use of the following software packages:

• ACD/SpecManager (NMR, UV-IR &MS Data Management)
• ACD/HNMR and ACD/CNMR Predictors and Database
• ACD/LogD Predictor
• ACD/LogP Predictor and Database
• ACD/pK_a Predictor and Database
• ACD/Boiling Point & Vapor Pressure Predictor
• ACD/Solubility DB
• ACD/HPLC and GC Simulator
• ACD/NAME Structure Naming

"ACD has been providing software to Astra chemists since 1995," said Tim Blacker, Sales Director at ACD. "We are excited that Astra has made the strong commitment to use ACD software on a global level and look forward to a continued mutually beneficial relationship with Astra in the future."

"Astra is pleased that through this Agreement we are able to conclude a wide deployment of the ACD Software," says Göran Stening, Information Systems Coordinator at Astra.

Advanced Chemistry Development Inc. is a leader in the field of physical property prediction, desktop spectroscopy management, systematic naming, and Web-based access to chemistry prediction. Founded in 1993 and with headquarters in Toronto, Canada, the company employs over 90 people and has established worldwide distribution channels. ACD Labs' mission is to define a new standard in capability for Chemistry based software addressing the needs of spectroscopy, physical property prediction, and systematic naming.

Astra is an international pharmaceutical company in a phase of rapid growth. The company focuses on areas of disease in which its proficiency in research can satisfy important medical needs. Astra currently employs approximately 22,000 employees worldwide.